Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

This publication has 13 references indexed in Scilit:

• Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study
  Blood Advances, 2026
• TCL-137: Duvelisib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma: Final Results From the Phase 2 PRIMO Trial
  Clinical Lymphoma Myeloma and Leukemia, 2025
• Peripheral T-cell lymphoma: are all patients high risk?
  Blood, 2024
• Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
  Blood, 2024
• Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma
  Blood Advances, 2024
• The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
  Blood, 2022
• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
  Leukemia, 2022
• The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
  Annals of Oncology, 2021
• The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma
  British Journal of Haematology, 2016
• Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
  Blood, 2010